Abbott Announces Share Repurchase Program

Strategy and Strength|Oct.15, 2019

Abbott's board has authorized the repurchase of up to $3 billion of the corporation's common shares. The new authorization is in addition to the $795 million unused portion of the previous program that was announced in September 2014. The repurchases may be made from time to time as market conditions warrant and are subject to regulatory considerations.

Abbott's strong cash flow has enabled it to invest in its business and return cash to shareholders through dividends and share repurchases. Abbott has a long history of returning value to shareholders, and during the last 10 years, the company has delivered approximately $31 billion in cash to its shareholders through dividends and share repurchases.

Like this article

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

INVESTORS

NEWSROOM

RESPONSIBILITY

SUBSCRIBE

CONSUMERS

HEALTHCARE PROFESSIONALS

CAREERS

ABOUT ABBOTT

CAREERS

INVESTORS

NEWSROOM

Responsibility

Partners

Contact

SITE MAP

POLICIES

privacy policy

Terms & Conditions